cyclosporine and Viral Conjunctivitis

cyclosporine has been researched along with Viral Conjunctivitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Han, G; Hawkins, BS; Kuo, IC; Leslie, L; Liu, SH; Ng, SM; Ren, M1
Ajili, F; Bouguerra, C; Gouider, D; Khairallah, M; Khallouli, A; Ksiaa, I; Maalej, A; Yousfi, MA1
Godehardt, E; Pfahl, HG; Reinhard, T; Sundmacher, R1

Reviews

1 review(s) available for cyclosporine and Viral Conjunctivitis

ArticleYear
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.
    The Cochrane database of systematic reviews, 2022, 03-03, Volume: 3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctivitis; Conjunctivitis, Viral; Cyclosporine; Dexamethasone; Female; Fluorometholone; Ganciclovir; Humans; Keratoconjunctivitis; Levofloxacin; Lubricant Eye Drops; Male; Middle Aged; Povidone-Iodine; Tacrolimus; Trifluridine; Young Adult

2022

Trials

1 trial(s) available for cyclosporine and Viral Conjunctivitis

ArticleYear
Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
    Cornea, 2021, Jun-01, Volume: 40, Issue:6

    Topics: Adenovirus Infections, Human; Administration, Ophthalmic; Adolescent; Adult; Aged; Child; Conjunctivitis, Viral; Cyclosporine; Double-Blind Method; Epithelium, Corneal; Female; Fluorometholone; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Treatment Outcome; Visual Acuity

2021

Other Studies

1 other study(ies) available for cyclosporine and Viral Conjunctivitis

ArticleYear
[Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2000, Volume: 97, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Conjunctivitis, Viral; Corneal Opacity; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Treatment Outcome

2000